Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Follows adults with chronic lymphocytic leukemia treated with venetoclax in routine care

Observes how venetoclax, alone or combined, works in adults with leukemia.

Plain-language title generated from the registry record
Registry title: Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting

Key facts

Where
Aschaffenburg, Augsburg, Bad Liebenwerda, Bad Mergentheim, Bad Reichenhall, Baden-Baden, Berlin, Bremerhaven, Cologne, Deggendorf, Dresden, Eisenach, Erlangen, Frankfurt (Oder), Frankfurt am Main, Freiburg im Breisgau, Goslar, Hagen, Halle, Hamburg, Hamm, Hanau, Hanover, Hof, Idar-Oberstein, Kaiserslautern, Kassel, Kronach, Landshut, Langenhessen, Lübeck, Magdeburg, Munich, Mutlangen, Neumünster, Neunkirchen, Neuss, Oldenburg, Osnabrück, Paderborn, Porta Westfalica, Potsdam, Regensburg, Rostock, Schwäbisch Hall, Schwetzingen, Stuttgart, Villingen-Schwenningen, and Westerstede, GermanySee the 61 sites

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The study includes adults with chronic lymphocytic leukemia (CLL) who are starting venetoclax treatment as prescribed by their doctor in real-life practice.

Age
18 years or older
Sex
All sexes can join
Disease stage
Chronic lymphocytic leukemia (CLL), any line of treatment, as long as venetoclax is used as the local label says

Read by machine on 12 November 2026.

Where in Germany

  • MVZ am Klinikum Aschaffenburg Onkologie /ID# 201548Aschaffenburg, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Studienzentrum Aschaffenburg /ID# 204125Aschaffenburg, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Gemeinschaftspraxis Dr. Heinrich und Prof. Bangerter /ID# 200950Augsburg, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Praxis Dr. Kreher /ID# 202604Bad Liebenwerda, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Caritas-Krankenhaus gGmbH /ID# 243212Bad Mergentheim, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Drs. Tanzer, Chirca, Stoeberl /ID# 202613Bad Reichenhall, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • MVZ Klinikum Mittelbaden GmbH /ID# 206207Baden-Baden, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Onkologie am Segelfliegerdamm /ID# 202603Berlin, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Onkologische Schwerpunktpraxis /ID# 200953Berlin, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Praxis am Volkspark /ID# 243195Berlin, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Praxis für Hämatologie und Onkologie /ID# 241763Berlin, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Ambulantes Tumorzentrum Bremerhaven /ID# 224353Bremerhaven, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Pioh Dres. Draube & Partner /ID# 239507Cologne, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Donauisar Klinikum Deggendorf /ID# 289012Deggendorf, GermanyContact: Johannes HuelsenbeckTaking people
  • BAG Freiberg-Richter, Jacobasch, Illmer, Wolf /ID# 201532Dresden, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Onkozentrum Dresden /ID# 202599Dresden, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Praxis Dres. Prange-Krex/Mohm /ID# 210049Dresden, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • St. Georg Klinikum Eisenach gemeinnützige GmbH (GKE) /ID# 250200Eisenach, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Internistische Schwerpunktpraxen, Erlangen /ID# 200949Erlangen, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Praxis Dres. Kiehl/Stein /ID# 210052Frankfurt (Oder), GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Varisano Klinikum Frankfurt Hoechst /ID# 288028Frankfurt am Main, GermanyContact: Johannes HuelsenbeckTaking people
  • Centrum fuer Haematologie und Onkologie Bethanien /ID# 206701Frankfurt am Main, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Klinikum Frankfurt Hoechst /ID# 210048Frankfurt am Main, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • MVZ Dres. Cordes & Partner /ID# 202598Frankfurt am Main, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Praxis fuer interdisziplinaere Onkolologie und Haematologie /ID# 206999Freiburg im Breisgau, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Onkologische Kooperation Harz /ID# 201550Goslar, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • MVZ Onkologie GmbH /ID# 212376Hagen, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Evidia MVZ III Oncology Halle /ID# 218354Halle, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • OncoResearch Lerchenfeld GmbH /ID# 205237Hamburg, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Onkologische Gemeinschaftspraxis /ID# 205239Hamburg, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Evangelisches Krankenhaus Hamm /ID# 206703Hamm, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Onkologische Schwerpunktpraxis Hanau /ID# 287948Hanau, GermanyContact: Johannes HuelsenbeckTaking people
  • OAZ Hannover /ID# 201538Hanover, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Studienbüro Kamal und Dorn GBR /ID# 234105Hanover, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Studienzentrum am Raschplatz /ID# 250180Hanover, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Onkologie Hof /ID# 201531Hof, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Klinikum Idar-Oberstein GmbH /ID# 210046Idar-Oberstein, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Hämatologie und Onkologie /ID# 205247Kaiserslautern, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Praxis Dres. Tebbe/Mayer /ID# 206730Kassel, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Praxis Dr. Stauch /ID# 202611Kronach, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • VK&K Studien GbR /ID# 202614Landshut, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Praxis Fuchs/Koehler /ID# 243215Langenhessen, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Luebecker Oncology Practice /ID# 200952Lübeck, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Gemeinschaftspraxis fuer Haematologie und Onkologie /ID# 281328Magdeburg, GermanyContact: Johannes HuelsenbeckTaking people
  • Haemato-Onkologie /ID# 205236Munich, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Stauferklinikum Schwaebisch Gmuend /ID# 201518Mutlangen, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Friedrich-Ebert-Krankenhaus GmbH /ID# 206206Neumünster, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Praxis Dr. Klaproth/Cura /ID# 216413Neunkirchen, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Praxis Dres. Plewe/Losem /ID# 202606Neuss, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Onkolologische Praxis Oldenburg /ID# 202607Oldenburg, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • MVZ der Paracelsus-Klinik /ID# 201541Osnabrück, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Bruederkrankenhaus St. Josef Paderborn /ID# 202600Paderborn, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Onkologische Praxis GbR /ID# 206705Porta Westfalica, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • MVZ f. Blut- u.Krebserkrankungen /ID# 206704Potsdam, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Praxis Dres. Krober/Stosiek /ID# 206729Regensburg, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Praxis Dres. Decker/Lakner/Leithäuser /ID# 206208Rostock, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Diakonieklinikum Schwaebisch Hall /ID# 206205Schwäbisch Hall, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • MVZ am Schlossgarten GmbH /ID# 210043Schwetzingen, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Onkologische Praxis /ID# 201545Stuttgart, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Schwarzwald-Baar-Klinikum /ID# 208176Villingen-Schwenningen, GermanyContact: Johannes HuelsenbeckNo longer taking part
  • Med. Studiengesellschaft Nord West GmbH /ID# 201535Westerstede, GermanyContact: Johannes HuelsenbeckNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
AbbVie
Trial code
NCT03342144
Record updated
21 October 2026
Original description
An observational study to assess the effectiveness, health economic-relevant costs and participant reported outcomes in participants with Chronic lymphocytic leukemia (CLL) receiving venetoclax as a monotherapy or in combination with rituximab, obinutuzumab, ibrutinib, or acalabrutinib as prescribed at the discretion of the physician and in accordance with local clinical practice and label.Read full original descriptionShow less

Observational Study of the Use of Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting in Austria, Germany and Switzerland

An observational study to assess the effectiveness, health economic-relevant costs and participant reported outcomes in participants with Chronic lymphocytic leukemia (CLL) receiving venetoclax as a monotherapy or in combination with rituximab, obinutuzumab, ibrutinib, or acalabrutinib as prescribed at the discretion of the physician and in accordance with local clinical practice and label.

Inclusion: Participant with chronic lymphocytic leukemia (CLL) who start venetoclax therapy can be included in the study if treated as specified in the local label for any specific line of treatment.

Exclusion: None.

ClinicalTrials.gov NCT03342144